Epigenetic Reader Domain

Related Products

Epigenetic regulators of gene expression and chromatin state include so-called writers, erasers, and readers of chromatin modifications.Well-characterized examples of reader domains include bromodomains typically binding acetyllysine and chromatin organization modifier (chromo), malignant brain tumor (MBT), plant homeodomain (PHD), and Tudor domains generally associating with methyllysine. Research on epigenetic readers has been tremendously influenced by the discovery of selective inhibitors targeting the bromodomain and extraterminal motif (BET) family of acetyl-lysine readers. The human genome encodes 46 proteins containing 61 bromodomains clustered into eight families. Distinct experimental approaches are used to identify the first BET inhibitors, GSK 525762A and (+)-JQ-1.

The Polycomb group (PcG) protein, enhancer of zeste homologue 2 (EZH2), has an essential role in promoting histone H3 lysine 27 trimethylation (H3K27me3) and epigenetic gene silencing. This function of EZH2 is important for cell proliferation and inhibition of cell differentiation, and is implicated in cancer progression. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. In many types of cancers including lymphomas and leukemia, EZH2 is postulated to exert its oncogenic effects via aberrant histone and DNA methylation, causing silencing of tumor suppressor genes.

p300/CBP is not only a transcriptional adaptor but also a histone acetyltransferase.

Epigenetic Reader Domain Related Products (52):

By Effects:	Inhibitors (50)

Cat. No.	Product Name	Effect	Purity

HY-13030

(+)-JQ-1 Inhibitor 99.86%

(+)-JQ-1 is a BET bromodomain inhibitor, with IC₅₀ of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)).
HY-13803

EPZ-6438 Inhibitor 99.63%

EPZ-6438 inhibits the activity of human PRC2-containing wild-type EZH2 with K_i of 2.5±0.5 nM.
HY-13470

GSK126 Inhibitor 99.32%

GSK126 is a potent, highly selective inhibitor of EZH2 methyltransferase activity with IC₅₀ of 9.9 nM.
HY-15743

OTX-015 Inhibitor 99.69%

OTX-015 is a new potent BRD2/3/4 inhibitor for cell adhesion with IC₅₀ values from 92 to 112 nM.
HY-13032

GSK 525762A Inhibitor 99.20%

GSK 525762A is a BET bromodomain inhibitor with IC₅₀ of 32.5-42.5 nM.
HY-100972

ARV-771 Inhibitor 99.44%

ARV-771 is a potent bromodomain and extra-terminal (BET) proteins degrader with K_d values of 4.7, 7.6, 7.6 nM against bromodomain 2, 3 and 4, respectively.
HY-101120

666-15 Inhibitor 98.65%

666-15 is a potent and selective CREB inhibitor with an IC₅₀ of 81 nM.
HY-100697

TPOP146 Inhibitor >98.0%

TPOP146 is a selective CBP/P300 benzoxazepine bromodomain inhibitor with K_d values of 134 nM and 5.02 μM for CBP and BRD4.
HY-50698

BI 2536 Inhibitor 99.19%

BI 2536 is a potent and selective inhibitor of Plk1 with IC₅₀ of 0.83 nM, and is also a potent inhibitor of BRD4 with IC₅₀ of 25 nM.
HY-13500

GSK343 Inhibitor 99.58%

GSK343 is a highly potent, selective, and cell-active EZH2 inhibitor with IC₅₀ of 4 nM.
HY-12186

3-Deazaneplanocin A hydrochloride Inhibitor

3-Deazaneplanocin A hydrochloride is a potent histone methyltransferase EZH2 inhibitor.

(+)-JQ-1	Inhibitor	99.86%
(+)-JQ-1 is a BET bromodomain inhibitor, with IC₅₀ of 77 nM/33 nM for the first and second bromodomain (BRD4(1/2)).

EPZ-6438	Inhibitor	99.63%
EPZ-6438 inhibits the activity of human PRC2-containing wild-type EZH2 with K_i of 2.5±0.5 nM.

GSK126	Inhibitor	99.32%
GSK126 is a potent, highly selective inhibitor of EZH2 methyltransferase activity with IC₅₀ of 9.9 nM.

OTX-015	Inhibitor	99.69%
OTX-015 is a new potent BRD2/3/4 inhibitor for cell adhesion with IC₅₀ values from 92 to 112 nM.

GSK 525762A	Inhibitor	99.20%
GSK 525762A is a BET bromodomain inhibitor with IC₅₀ of 32.5-42.5 nM.

ARV-771	Inhibitor	99.44%
ARV-771 is a potent bromodomain and extra-terminal (BET) proteins degrader with K_d values of 4.7, 7.6, 7.6 nM against bromodomain 2, 3 and 4, respectively.

666-15	Inhibitor	98.65%
666-15 is a potent and selective CREB inhibitor with an IC₅₀ of 81 nM.

TPOP146	Inhibitor	>98.0%
TPOP146 is a selective CBP/P300 benzoxazepine bromodomain inhibitor with K_d values of 134 nM and 5.02 μM for CBP and BRD4.

BI 2536	Inhibitor	99.19%
BI 2536 is a potent and selective inhibitor of Plk1 with IC₅₀ of 0.83 nM, and is also a potent inhibitor of BRD4 with IC₅₀ of 25 nM.

GSK343	Inhibitor	99.58%
GSK343 is a highly potent, selective, and cell-active EZH2 inhibitor with IC₅₀ of 4 nM.

3-Deazaneplanocin A hydrochloride	Inhibitor
3-Deazaneplanocin A hydrochloride is a potent histone methyltransferase EZH2 inhibitor.

HY-11006

KU-57788	Inhibitor	98.74%
KU-57788 is a potent and selective inhibitor of DNA-PK, a modest inhibitor of BRD4 and BRDT, with IC₅₀s of 13 nM, 1 μM and 3.5 μM, respectively, and also increases CRISPR/Cas9-mediated editing frequencies.

HY-13235

I-BET151 Inhibitor 98.47%

I-BET151 is a BET bromodomain inhibitor, inhibits BRD4, BRD2, and BRD3 with pIC₅₀ of 6.1, 6.3, and 6.6, respectively.
HY-15646

UNC1999 Inhibitor 99.02%

UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH2 (IC₅₀<10 nM) and EZH1 (IC₅₀=45±3 nM).
HY-15826

SGC-CBP30 Inhibitor 99.19%

SGC-CBP30 is a potent CREBBP/EP300 bromodomain inhibitor with IC50 of 21-69 and 38 nM for CREBBP and EP300 bromodomains, respectively)
HY-16652

RVX-208 Inhibitor 99.19%

RVX-208 is an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.
HY-78695

JQ-1 carboxylic acid Inhibitor 99.49%

(+)-JQ1 carboxylic acid is the carboxylic acid form of (+)-JQ1 for derivative synthesis.

I-BET151	Inhibitor	98.47%
I-BET151 is a BET bromodomain inhibitor, inhibits BRD4, BRD2, and BRD3 with pIC₅₀ of 6.1, 6.3, and 6.6, respectively.

UNC1999	Inhibitor	99.02%
UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH2 (IC₅₀<10 nM) and EZH1 (IC₅₀=45±3 nM).

SGC-CBP30	Inhibitor	99.19%
SGC-CBP30 is a potent CREBBP/EP300 bromodomain inhibitor with IC50 of 21-69 and 38 nM for CREBBP and EP300 bromodomains, respectively)

RVX-208	Inhibitor	99.19%
RVX-208 is an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.

JQ-1 carboxylic acid	Inhibitor	99.49%
(+)-JQ1 carboxylic acid is the carboxylic acid form of (+)-JQ1 for derivative synthesis.

HY-16954

ARV-825	Inhibitor	99.35%
ARV-825 is a BRD4 inhibitor with DC50 (50% of maximum degradation) ＜1nM for Burkitt's lymphoma (BL) cell lines. Affinity to BD1 and BD2 of BRD4 by ARV-825 is 90 and 28 nM, respectively.

HY-10409

TG-101348	Inhibitor	98.28%
TG-101348 (SAR302503) is a selective inhibitor of JAK2 with IC50 of 3 nM, 35- and 334-fold more selective for JAK2 versus JAK1 and JAK3, TG-101348 also inhibit BRD4 with IC50 of 340 nM.

HY-12856

GSK503 Inhibitor 99.29%

GSK503 is a potent and specific inhibitor of EZH2 methyltransferase with K_i^app values of 3 to 27 nM.

Name
Email *

	Sorry, but the email address you supplied was invalid.